By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Arrowhead Pharmaceuticals (Formerly Known As Arrowhead Research Corporation) 

1118 East Green Street

Pasadena  California  91106  U.S.A.
Phone: 626-792-5549 Fax: 626-792-5554


Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead’s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.

Key Statistics

Ownership: Public

Web Site: Arrowhead Pharma
Symbol: ARWR

Medical Device

Company News
Arrowhead Pharma (ARWR) Presents ARC-AAT Clinical Data At The International Liver Congress 4/24/2017 6:27:16 AM
Arrowhead Pharma (ARWR) Presents ARC-520 And ARC-521 Clinical Data At The International Liver Congress 4/20/2017 11:09:48 AM
Arrowhead Pharma (ARWR) Adopts Stockholder Rights Agreement 3/23/2017 6:25:01 AM
Arrowhead Pharma (ARWR) Reports Fiscal 2017 First Quarter Results 2/7/2017 6:39:07 AM
Arrowhead Pharma (ARWR) To Webcast Fiscal 2017 First Quarter Results 1/31/2017 9:24:36 AM
Arrowhead Pharma (ARWR) Provides Response To New Minority Shareholder Announcement 1/9/2017 12:48:39 PM
Arrowhead Pharma (ARWR) Reports Fiscal 2016 Year End Results 12/15/2016 10:35:24 AM
Arrowhead Pharma (ARWR) To Webcast Fiscal 2016 Year End Results 12/8/2016 10:57:54 AM
Floundering SoCal Biotech Arrowhead Pharma (ARWR) Fires CSO, Effective Later This Month 12/2/2016 5:53:22 AM
SoCal's Arrowhead Pharma (ARWR) Stock Craters After Terminating 30% of Workforce, Discontinuing Work on Lead Hep B Drugs 11/30/2016 5:40:03 AM